CN111280522A - Anti-virus mask and production method thereof - Google Patents
Anti-virus mask and production method thereof Download PDFInfo
- Publication number
- CN111280522A CN111280522A CN202010121383.3A CN202010121383A CN111280522A CN 111280522 A CN111280522 A CN 111280522A CN 202010121383 A CN202010121383 A CN 202010121383A CN 111280522 A CN111280522 A CN 111280522A
- Authority
- CN
- China
- Prior art keywords
- parts
- virus
- layer
- mask
- particle composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D13/00—Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
- A41D13/05—Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches protecting only a particular body part
- A41D13/11—Protective face masks, e.g. for surgical use, or for use in foul atmospheres
- A41D13/1192—Protective face masks, e.g. for surgical use, or for use in foul atmospheres with antimicrobial agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Textile Engineering (AREA)
- Respiratory Apparatuses And Protective Means (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses an anti-virus mask, which comprises a bottom layer, an anti-virus layer and a surface layer which are sequentially arranged, wherein an anti-virus particle composition is adhered to the anti-virus layer; the antiviral particle composition comprises the following components in parts by weight: 5-15 parts of nard, 5-15 parts of rhizoma atractylodis, 5-15 parts of rhizoma kaempferiae, 5-15 parts of rheum officinale, 5-15 parts of sandalwood, 5-15 parts of calamus, 1-10 parts of radix angelicae, 1-5 parts of borneol and 3-8 parts of liquorice. The anti-virus mask provided by the invention has an anti-virus layer besides a non-woven fabric hydrophobic layer of a common medical mask, particularly has a better protection effect against novel coronavirus (COVID-19), and is more comfortable to wear, and has the advantages of antipyretic and dampness resolving, fragrance and dirt avoiding, consciousness restoring and resuscitation inducing, good air permeability and good effect. The invention also discloses a production method of the anti-virus mask, which has simple equipment and convenient operation and is suitable for large-scale production.
Description
Technical Field
The invention relates to the field of protective masks, in particular to an anti-virus mask and a production method thereof.
Background
At present, pathogenic microorganisms such as bacteria and viruses seriously threaten the health of people for a long time. The COVID-19 pneumonia has similar clinical symptoms of respiratory system diseases with SARS, and is characterized by long latent period, strong infectivity, relatively low fatality rate and the like, and high attention must be paid to the severity and positive prevention and control of the harm of the diseases.
For the mobile population, the simplest, economical and effective method for blocking respiratory tract transmitted diseases such as influenza is to wear a mask. However, after the retrieval of the standards of products in China, no national, industrial and local standards of the anti-virus mask exist; there is also no genuine anti-virus mask on the market that is approved by the national drug administration. The common medical mask only utilizes the hydrophobicity of the surface to prevent the spray, and the prevention effect is limited.
Disclosure of Invention
The invention provides an anti-virus mask and a production method thereof for solving the problems in the prior art, the anti-virus mask has an anti-virus layer besides a hydrophobic layer of a common medical mask, has a better protection effect, and is scourge-clearing, dampness-resolving, aromatic and dirt-avoiding.
In order to achieve the purpose, the invention adopts the following technical scheme:
the invention provides an anti-virus mask, which comprises a bottom layer, an anti-virus layer and a surface layer which are sequentially arranged, wherein an anti-virus particle composition is adhered to the anti-virus layer;
the antiviral particle composition comprises the following components in parts by weight: 5-15 parts of nard, 5-15 parts of rhizoma atractylodis, 5-15 parts of rhizoma kaempferiae, 5-15 parts of rheum officinale, 5-15 parts of sandalwood, 5-15 parts of calamus, 1-10 parts of radix angelicae, 1-5 parts of borneol and 3-8 parts of liquorice.
Further, the antiviral particle composition comprises the following components in parts by weight: 8-10 parts of nard, 7-10 parts of rhizoma atractylodis, 8-10 parts of rhizoma kaempferiae, 10-12 parts of rheum officinale, 10-13 parts of sandalwood, 6-10 parts of calamus, 3-5 parts of radix angelicae, 2-3 parts of borneol and 6-8 parts of liquorice.
Further, the bottom layer and the surface layer are both PP non-woven fabrics.
Further, the anti-virus layer is an ES fiber layer adhered with the anti-virus particle composition.
Further preferably, the antiviral particle composition on the ES fiber layer has an adhesion amount of 80 to 200g/m2。
Further, the antiviral particle composition has an average particle size of 50 to 100 mesh.
The second aspect of the invention provides a method for producing an anti-virus mask, which comprises the following preparation steps:
s1: compounding ES fibers and PP non-woven fabrics into composite fiber cloth, and uniformly adding an antiviral particle composition to the ES fiber side of the composite fiber cloth through a material distribution device;
s2: enabling the composite fiber cloth added with the antiviral particle composition to pass through a hot air spraying device, wherein an air outlet of the hot air spraying device is opposite to the ES fiber side of the composite fiber cloth, and the PP non-woven fabric side of the composite fiber cloth corresponds to a negative pressure air suction device in the hot air spraying device;
s3: passing the composite fiber cloth treated by the S2 through a hot air curing device;
s4: compounding a PP non-woven fabric surface layer to the ES fiber layer of the composite fiber cloth solidified by S3;
s5: pressurizing, flattening and performing subsequent conventional treatment to obtain the antivirus mask.
Further, in S3, the temperature of the hot air curing device is controlled at 155 ± 5 ℃.
By adopting the technical scheme, compared with the prior art, the invention has the following technical effects:
the anti-virus mask provided by the invention has a non-woven fabric hydrophobic layer of a common medical mask, has an anti-virus layer, is particularly excellent in protection effect against novel coronavirus (COVID-19), is pestilence-clearing and dampness-resolving, aromatic and dirt-avoiding, refreshes and resuscitates, is good in air permeability, and is more comfortable to wear.
The production method of the anti-virus mask has the advantages of simple equipment and convenient operation, and is suitable for large-scale production.
Detailed Description
The invention provides an anti-virus mask, which comprises a bottom layer, an anti-virus layer and a surface layer which are sequentially arranged, wherein an anti-virus particle composition is adhered to the anti-virus layer;
the antiviral particle composition comprises the following components in parts by weight: 5-15 parts of nard, 5-15 parts of rhizoma atractylodis, 5-15 parts of rhizoma kaempferiae, 5-15 parts of rheum officinale, 5-15 parts of sandalwood, 5-15 parts of calamus, 1-10 parts of radix angelicae, 1-5 parts of borneol and 3-8 parts of liquorice.
Further preferably, the antiviral particle composition comprises the following components in parts by weight: 8-10 parts of nard, 7-10 parts of rhizoma atractylodis, 8-10 parts of rhizoma kaempferiae, 10-12 parts of rheum officinale, 10-13 parts of sandalwood, 6-10 parts of calamus, 3-5 parts of radix angelicae, 2-3 parts of borneol and 6-8 parts of liquorice.
The antiviral particle composition comprises the following medicinal components: rhizoma nardostachyos, rhizoma atractylodis, rhizoma kaempferiae, rheum officinale, sandalwood, calamus, radix angelicae, borneol and liquorice.
The analysis of the formulation is as follows:
rhizoma atractylodis, rhizoma nardostachyos, rhizoma atractylodis;
sandalwood, grassleaf sweelflag rhizome, dahurian angelica root and borneol are aromatic, eliminate dampness, avoid dirt, refresh the brain and induce resuscitation, and are used as ministerial drugs together;
rhizoma kaempferiae and radix et rhizoma Rhei are used as adjuvant drugs for promoting qi circulation, relieving pain, promoting bile flow and eliminating dampness;
the liquorice is used as a guiding drug for harmonizing the effects of the other drugs in the recipe;
the medicines are combined to play the effects of eliminating dampness and removing dirt, and restoring consciousness and inducing resuscitation.
The research on the main compound compatibility structure of the antiviral particle composition shows that:
(1) the rhizoma atractylodis is matched with angelica dahurica, and the famous formula of the Huoxiang Zhengqi powder and the Jiuwei Qianghuo decoction for treating exogenous wind-cold and internal cold-dampness resistance in traditional Chinese medicine are taken as main structures, so that the traditional Chinese medicine has spasmolysis, intestinal barrier function protection and bacteriostasis.
(2) The rhizoma atractylodis and the rhubarb have unique curative effects on damp-heat retention in the interior, blockage of middle energizer, irregular transportation and transformation functions of the spleen and the stomach, enteritis diarrhea caused by abnormal conduction function of the large intestine, abdominal pain damp-heat dysentery and the like due to exogenous damp-heat toxin, and have obvious bacteriostatic action on pathogenic escherichia coli, shigella dysenteriae, staphylococcus aureus and the like.
(3) The related research shows that the methyl eugenol, cis-methyl isoeugenol, trans-methyl isoeugenol, Y-asarone and B-asarone in the grassleaf sweelflag rhizome and the d-santalene, Epi-p-santalene, curcumene, d-santalol, trans-d-Bergamotol, santal E, cis-Epi-p-santalol, B-santalol and the like in the borneol can play a role in protecting nerve cells. And related researches show that the rhizoma acori graminei and borneol can reduce the activity of platelets and have the effects of resisting platelet aggregation and adhesion.
In conclusion, the main components contained in the formula have the effects of restoring consciousness, inducing resuscitation, clearing damp, removing dirt, inhibiting bacteria and protecting gastrointestinal tract.
The anti-virus mask disclosed by the invention has an anti-virus layer besides a non-woven fabric hydrophobic layer of a common medical mask, and the anti-virus particle composition loaded on the anti-virus layer has a better protection effect especially on novel coronavirus (COVID-19); and has the advantages of antipyresis, dampness eliminating, fragrance, filth avoiding, consciousness restoring, resuscitation inducing, good air permeability, and comfortable wearing.
In one embodiment of the present invention, the bottom layer and the surface layer are both PP nonwoven fabrics, and the hydrophobic PP nonwoven fabric plays a role of the first heavy protection.
In one embodiment of the present invention, the anti-virus layer is an ES fiber layer to which the anti-virus particle composition is adhered; the antiviral particle composition is adhered to the ES fiber layer in an amount of 80-200g/m2。
In one embodiment of the present invention, the antiviral particulate composition has an average particle diameter of 50 to 100 mesh; the antiviral particle composition with the mesh number is adhered to the ES fiber layer, so that the ES fiber layer is not easy to fall off; even if falling off, the medicine can not be inhaled into human body.
The invention also provides a production method of the anti-virus mask, which comprises the following preparation steps:
s1: compounding the ES fibers and the PP non-woven fabric into composite fiber cloth, and uniformly adding the antiviral particle composition to the ES fiber side of the composite fiber cloth through a material distribution device;
s2: enabling the composite fiber cloth added with the antiviral particle composition to pass through a hot air spraying device, wherein an air outlet of the hot air spraying device is opposite to the ES fiber side of the composite fiber cloth, and the PP non-woven fabric side of the composite fiber cloth corresponds to a negative pressure air suction device in the hot air spraying device;
s3: the composite fiber cloth processed by the S2 passes through a hot air curing device, and the temperature of the hot air curing device is controlled at 155 +/-5 ℃;
s4: compounding the PP non-woven fabric surface layer to the ES fiber layer of the composite fiber cloth solidified by S3;
s5: pressurizing, flattening and performing subsequent conventional treatment to obtain the antivirus mask.
The present invention will now be described in detail and specifically with reference to the following examples so as to provide a better understanding of the present invention, but the following examples are not intended to limit the scope of the present invention.
Example 1
An antivirus mask comprises a PP non-woven fabric bottom layer, an antivirus layer and a PP non-woven fabric surface layer which are sequentially arranged, wherein an antivirus particle composition is adhered to the antivirus layer;
the antiviral particle composition comprises the following components in parts by weight: 10 parts of nard, 10 parts of rhizoma atractylodis, 10 parts of rhizoma kaempferiae, 10 parts of rheum officinale, 10 parts of sandalwood, 10 parts of calamus, 5 parts of angelica dahurica, 3 parts of borneol and 6 parts of licorice.
The anti-virus mask is produced according to the following preparation steps:
s1: compounding ES fibers and PP non-woven fabrics into composite fiber cloth, and uniformly adding an antiviral particle composition to the ES fiber side of the composite fiber cloth through a material distribution device, wherein the average particle diameter of the antiviral particle composition is 50-100 meshes;
s2: enabling the composite fiber cloth added with the antiviral particle composition to pass through a hot air spraying device, wherein an air outlet of the hot air spraying device is opposite to the ES fiber side of the composite fiber cloth, and the PP non-woven fabric side of the composite fiber cloth corresponds to a negative pressure air suction device in the hot air spraying device;
s3: the composite fiber cloth processed by the S2 passes through a hot air curing device, and the temperature of the hot air curing device is controlled at 155 +/-5 ℃;
s4: compounding the PP non-woven fabric surface layer to the ES fiber layer of the composite fiber cloth solidified by S3;
s5: pressurizing, flattening and performing subsequent conventional treatment to obtain the antivirus mask.
The prepared antivirus mask has an ES fiber layer with antiviral particle composition adhered at 80-200g/m2。
Example 2
An antivirus mask comprises a PP non-woven fabric bottom layer, an antivirus layer and a PP non-woven fabric surface layer which are sequentially arranged, wherein an antivirus particle composition is adhered to the antivirus layer;
the antiviral particle composition comprises the following components in parts by weight: 8 parts of nard, 7 parts of rhizoma atractylodis, 8 parts of rhizoma kaempferiae, 10 parts of rhubarb, 10 parts of sandalwood, 6 parts of calamus, 3 parts of angelica dahurica, 2 parts of borneol and 6 parts of liquorice.
The anti-virus mask is produced according to the following preparation steps:
s1: compounding ES fibers and PP non-woven fabrics into composite fiber cloth, and uniformly adding an antiviral particle composition to the ES fiber side of the composite fiber cloth through a material distribution device, wherein the average particle diameter of the antiviral particle composition is 50-100 meshes;
s2: enabling the composite fiber cloth added with the antiviral particle composition to pass through a hot air spraying device, wherein an air outlet of the hot air spraying device is opposite to the ES fiber side of the composite fiber cloth, and the PP non-woven fabric side of the composite fiber cloth corresponds to a negative pressure air suction device in the hot air spraying device;
s3: the composite fiber cloth processed by the S2 passes through a hot air curing device, and the temperature of the hot air curing device is controlled at 155 +/-5 ℃;
s4: compounding the PP non-woven fabric surface layer to the ES fiber layer of the composite fiber cloth solidified by S3;
s5: pressurizing, flattening and performing subsequent conventional treatment to obtain the antivirus mask.
The prepared antivirus mask has an ES fiber layer with antiviral particle composition adhered at 80-200g/m2。
Example 3
An antivirus mask comprises a PP non-woven fabric bottom layer, an antivirus layer and a PP non-woven fabric surface layer which are sequentially arranged, wherein an antivirus particle composition is adhered to the antivirus layer;
the antiviral particle composition comprises the following components in parts by weight: 10 parts of nard, 0 part of rhizoma atractylodis, 10 parts of rhizoma kaempferiae, 12 parts of rheum officinale, 13 parts of sandalwood, 10 parts of calamus, 5 parts of angelica dahurica, 3 parts of borneol and 8 parts of licorice.
The anti-virus mask is produced according to the following preparation steps:
s1: compounding ES fibers and PP non-woven fabrics into composite fiber cloth, and uniformly adding an antiviral particle composition to the ES fiber side of the composite fiber cloth through a material distribution device, wherein the average particle diameter of the antiviral particle composition is 50-100 meshes;
s2: enabling the composite fiber cloth added with the antiviral particle composition to pass through a hot air spraying device, wherein an air outlet of the hot air spraying device is opposite to the ES fiber side of the composite fiber cloth, and the PP non-woven fabric side of the composite fiber cloth corresponds to a negative pressure air suction device in the hot air spraying device;
s3: the composite fiber cloth processed by the S2 passes through a hot air curing device, and the temperature of the hot air curing device is controlled at 155 +/-5 ℃;
s4: compounding the PP non-woven fabric surface layer to the ES fiber layer of the composite fiber cloth solidified by S3;
s5: pressurizing, flattening and performing subsequent conventional treatment to obtain the antivirus mask.
The prepared antivirus mask has an ES fiber layer with antiviral particle composition adhered at 80-200g/m2。
Comparative example
The anti-virus mask (covi-19 traditional Chinese medicine type mask) prepared by the present invention was subjected to a correlation test with a commercially available mask, and the results are shown in table 1:
TABLE 1
Rating standard:
air permeability: a suction resistance is less than or equal to 50 Pa; b, the air suction resistance is less than or equal to 90 Pa; c, the air suction resistance is more than 90 Pa;
effective wearing time: a is less than 12 hours; b is less than 8 hours; c is less than 6 hours;
antiviral properties: a can block particles less than 100 nm; b can block particles less than 200 nm; c can block particles larger than or equal to 200nm
Safety: a is provided with non-woven fabrics, and the wearer can not be allergic; b, non-woven fabrics exist but part of people can be allergic; allergy to C nonwoven
Comfort: a, the comfort level is excellent; b, comfort level is good; c, comfort level is general.
The embodiments of the present invention have been described in detail, but the embodiments are only examples, and the present invention is not limited to the above-described embodiments. Any equivalent modifications and substitutions to those skilled in the art are also within the scope of the present invention. Therefore, equivalent changes and modifications made without departing from the spirit and scope of the present invention should be covered by the present invention.
Claims (8)
1. An anti-virus mask is characterized by comprising a bottom layer, an anti-virus layer and a surface layer which are sequentially arranged, wherein an anti-virus particle composition is adhered to the anti-virus layer;
the antiviral particle composition comprises the following components in parts by weight: 5-15 parts of nard, 5-15 parts of rhizoma atractylodis, 5-15 parts of rhizoma kaempferiae, 5-15 parts of rheum officinale, 5-15 parts of sandalwood, 5-15 parts of calamus, 1-10 parts of radix angelicae, 1-5 parts of borneol and 3-8 parts of liquorice.
2. The anti-virus mask according to claim 1, wherein the anti-virus particle composition comprises the following components in parts by weight: 8-10 parts of nard, 7-10 parts of rhizoma atractylodis, 8-10 parts of rhizoma kaempferiae, 10-12 parts of rheum officinale, 10-13 parts of sandalwood, 6-10 parts of calamus, 3-5 parts of radix angelicae, 2-3 parts of borneol and 6-8 parts of liquorice.
3. The anti-virus mask as claimed in claim 1, wherein the bottom layer and the surface layer are both PP non-woven fabrics.
4. The anti-virus mask of claim 1 wherein the anti-virus layer is an ES fiber layer to which an anti-virus particle composition is adhered.
5. The anti-virus mask as claimed in claim 4, wherein the adhesion amount of the anti-virus particle composition on the ES fiber layer is 80 to 200g/m2。
6. The anti-virus mask as claimed in claim 1, wherein the mean particle size of the anti-virus particle composition is 50 to 100 mesh.
7. The method for producing an anti-virus mask according to any one of claims 1 to 6, comprising the steps of:
s1: compounding ES fibers and PP non-woven fabrics into composite fiber cloth, and uniformly adding an antiviral particle composition to the ES fiber side of the composite fiber cloth through a material distribution device;
s2: enabling the composite fiber cloth added with the antiviral particle composition to pass through a hot air spraying device, wherein an air outlet of the hot air spraying device is opposite to the ES fiber side of the composite fiber cloth, and the PP non-woven fabric side of the composite fiber cloth corresponds to a negative pressure air suction device in the hot air spraying device;
s3: passing the composite fiber cloth treated by the S2 through a hot air curing device;
s4: compounding a PP non-woven fabric surface layer to the ES fiber layer of the composite fiber cloth solidified by S3;
s5: pressurizing, flattening and performing subsequent conventional treatment to obtain the antivirus mask.
8. The production method according to claim 7, wherein in S3, the temperature of the hot air curing device is controlled at 155 ± 5 ℃.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010121383.3A CN111280522A (en) | 2020-02-26 | 2020-02-26 | Anti-virus mask and production method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010121383.3A CN111280522A (en) | 2020-02-26 | 2020-02-26 | Anti-virus mask and production method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111280522A true CN111280522A (en) | 2020-06-16 |
Family
ID=71024612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010121383.3A Pending CN111280522A (en) | 2020-02-26 | 2020-02-26 | Anti-virus mask and production method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111280522A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112273762A (en) * | 2020-10-27 | 2021-01-29 | 昆山洁宏无纺布制品有限公司 | Preparation method of efficient anti-virus waterproof isolation clothes |
| CN112741121A (en) * | 2021-01-21 | 2021-05-04 | 广西壮族自治区中国科学院广西植物研究所 | Application of plant essential oil and perfume compound in preparation of sanitary product for inhibiting infection force of novel coronavirus |
| CN114515324A (en) * | 2021-11-24 | 2022-05-20 | 兰州大学第一医院 | Traditional Chinese medicine epidemic prevention aromatherapy composition and product thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1114232A (en) * | 1994-06-14 | 1996-01-03 | 西北大学 | Gauze mask |
| CN1548127A (en) * | 2003-05-21 | 2004-11-24 | 胡庆林 | Epidemic preventing fragrant pendant |
| CN104116228A (en) * | 2014-07-31 | 2014-10-29 | 庄雅哲 | Production method of granular active carbon mask |
| CN108634441A (en) * | 2018-06-21 | 2018-10-12 | 湖州市中医院 | A kind of gauze mask with Chinese medicine bag for preventing infectious disease |
-
2020
- 2020-02-26 CN CN202010121383.3A patent/CN111280522A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1114232A (en) * | 1994-06-14 | 1996-01-03 | 西北大学 | Gauze mask |
| CN1548127A (en) * | 2003-05-21 | 2004-11-24 | 胡庆林 | Epidemic preventing fragrant pendant |
| CN104116228A (en) * | 2014-07-31 | 2014-10-29 | 庄雅哲 | Production method of granular active carbon mask |
| CN108634441A (en) * | 2018-06-21 | 2018-10-12 | 湖州市中医院 | A kind of gauze mask with Chinese medicine bag for preventing infectious disease |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112273762A (en) * | 2020-10-27 | 2021-01-29 | 昆山洁宏无纺布制品有限公司 | Preparation method of efficient anti-virus waterproof isolation clothes |
| CN112741121A (en) * | 2021-01-21 | 2021-05-04 | 广西壮族自治区中国科学院广西植物研究所 | Application of plant essential oil and perfume compound in preparation of sanitary product for inhibiting infection force of novel coronavirus |
| CN114515324A (en) * | 2021-11-24 | 2022-05-20 | 兰州大学第一医院 | Traditional Chinese medicine epidemic prevention aromatherapy composition and product thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111280522A (en) | Anti-virus mask and production method thereof | |
| CN111097040A (en) | Antiviral lung-heat clearing peptide | |
| CN111097007A (en) | Multifunctional medicine core, mask and application | |
| CN105456865B (en) | Traditional Chinese medicine bag for odor therapy, preparation method thereof and traditional Chinese medicine odor therapy device | |
| Rastmanesh et al. | Call for mobilization of functional foods, antioxidants, and herbal antivirals in support of international campaign to control coronavirus | |
| CN102178892B (en) | Chinese medicinal composition for treating depression | |
| CN104799639A (en) | Traditional Chinese medicine pillow for treating migraine | |
| CN102008557B (en) | Anti-influenza detoxifying capsules and preparation method thereof | |
| CN106074925B (en) | A kind of respiration health medicine and its match device | |
| CN106692504A (en) | Anti-haze health food capable of clearing heat from throat, relieving cough and moistening lung and preparation method thereof | |
| CN104547682A (en) | Composition with effects of clearing away lung heat, relieving sore throat, cooling throat and relieving asthma | |
| CN111514246A (en) | Traditional Chinese medicine composition and mask for preventing novel coronavirus pneumonia | |
| CN104107258A (en) | Medicinal composition for treating viral keratitis | |
| CN106491714A (en) | A kind of child's collunarium antibacterial liquid | |
| CN111436691A (en) | Chinese herbal tea epidemic prevention mask | |
| CN112602732A (en) | Epidemic prevention traditional Chinese medicine essential oil formula | |
| CN102526236A (en) | Pharmaceutical formulation for treating influenza and preparation method thereof | |
| CN102961487B (en) | Compound combination made from pure traditional Chinese medicines and used for treating henpox and preparation method of combination | |
| CN103386081B (en) | Traditional Chinese medicine preparation for curing respiratory tract infection in clinical nursing | |
| CN104686596A (en) | Air disinfectant | |
| CN109718262A (en) | A kind of Chinese medicine composition for treating allergic rhinitis | |
| CN110064033A (en) | A kind of pharmaceutical composition and preparation method thereof of relieving cough and reducing sputum blood coagulation | |
| CN104666420A (en) | A medicine for treating rhinitis | |
| CN101732638B (en) | Chinese medicament for treating pulmonary tuberculosis | |
| CN105362548A (en) | Traditional Chinese medicine for treating allergic asthma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200616 |